DIVERSIFIED HEALTHCARE TRUST (DHC) Stock Fundamental Analysis

NASDAQ:DHC • US25525P1075

6.76 USD
-0.05 (-0.73%)
At close: Feb 27, 2026
6.76 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Fundamental Rating

2

DHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. While DHC seems to be doing ok healthwise, there are quite some concerns on its profitability. DHC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • DHC had negative earnings in the past year.
  • DHC had a positive operating cash flow in the past year.
  • DHC had negative earnings in 4 of the past 5 years.
  • In multiple years DHC reported negative operating cash flow during the last 5 years.
DHC Yearly Net Income VS EBIT VS OCF VS FCFDHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

  • DHC has a worse Return On Assets (-7.52%) than 87.70% of its industry peers.
  • With a Return On Equity value of -20.85%, DHC is not doing good in the industry: 82.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHC Yearly ROA, ROE, ROICDHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • DHC's Gross Margin of 17.58% is on the low side compared to the rest of the industry. DHC is outperformed by 92.62% of its industry peers.
  • DHC's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHC Yearly Profit, Operating, Gross MarginsDHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

  • DHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for DHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DHC Yearly Shares OutstandingDHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHC Yearly Total Debt VS Total AssetsDHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • DHC has an Altman-Z score of -0.20. This is a bad value and indicates that DHC is not financially healthy and even has some risk of bankruptcy.
  • DHC has a Altman-Z score of -0.20. This is in the lower half of the industry: DHC underperforms 78.69% of its industry peers.
  • A Debt/Equity ratio of 1.61 is on the high side and indicates that DHC has dependencies on debt financing.
  • The Debt to Equity ratio of DHC (1.61) is worse than 60.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACC6.27%
DHC Yearly LT Debt VS Equity VS FCFDHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 6.66 indicates that DHC has no problem at all paying its short term obligations.
  • DHC has a Current ratio of 6.66. This is amongst the best in the industry. DHC outperforms 99.18% of its industry peers.
  • A Quick Ratio of 6.66 indicates that DHC has no problem at all paying its short term obligations.
  • DHC has a Quick ratio of 6.66. This is amongst the best in the industry. DHC outperforms 99.18% of its industry peers.
Industry RankSector Rank
Current Ratio 6.66
Quick Ratio 6.66
DHC Yearly Current Assets VS Current LiabilitesDHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.38% over the past year.
EPS 1Y (TTM)12.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.01%

3.2 Future

  • DHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.39% yearly.
  • Based on estimates for the next years, DHC will show a small growth in Revenue. The Revenue will grow by 3.88% on average per year.
EPS Next Y36.87%
EPS Next 2Y18.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.64%
Revenue Next 2Y3.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

DHC Yearly Revenue VS EstimatesDHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHC Yearly EPS VS EstimatesDHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DHC. In the last year negative earnings were reported.
  • Also next year DHC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHC Price Earnings VS Forward Price EarningsDHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • DHC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DHC is more expensive than 66.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.47
DHC Per share dataDHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as DHC's earnings are expected to grow with 18.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.39%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

  • DHC has a yearly dividend return of 0.63%, which is pretty low.
  • Compared to an average industry Dividend Yield of 6.76, DHC's dividend is way lower than its industry peers. On top of this 94.26% of the companies listed in the same industry pay a better dividend than DHC!
  • With a Dividend Yield of 0.63, DHC pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.63%

5.2 History

  • The dividend of DHC decreases each year by -45.60%.
  • DHC has paid a dividend for at least 10 years, which is a reliable track record.
  • DHC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
DHC Yearly Dividends per shareDHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of DHC are negative and hence is the payout ratio. DHC will probably not be able to sustain this dividend level.
DP-2.74%
EPS Next 2Y18.39%
EPS Next 3YN/A
DHC Yearly Income VS Free CF VS DividendDHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

DIVERSIFIED HEALTHCARE TRUST

NASDAQ:DHC (2/27/2026, 8:00:02 PM)

After market: 6.76 0 (0%)

6.76

-0.05 (-0.73%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners76.96%
Inst Owner Change3.06%
Ins Owners0.48%
Ins Owner Change-8.52%
Market Cap1.64B
Revenue(TTM)N/A
Net Income(TTM)-352.11M
Analysts74.29
Price Target5.87 (-13.17%)
Short Float %2.7%
Short Ratio3.99
Dividend
Industry RankSector Rank
Dividend Yield 0.63%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-26
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)0%
PT rev (3m)9.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF 87.6
P/B 0.97
P/tB 0.97
EV/EBITDA 17.47
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY1.14%
SpS6.35
BVpS6.97
TBVpS6.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.52%
ROE -20.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.58%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 11.41
Cap/Depr 65.29%
Cap/Sales 11.78%
Interest Coverage N/A
Cash Conversion 7.83%
Profit Quality N/A
Current Ratio 6.66
Quick Ratio 6.66
Altman-Z -0.2
F-Score6
WACC6.27%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y36.87%
EPS Next 2Y18.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.01%
Revenue Next Year3.64%
Revenue Next 2Y3.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year382.47%
EBIT Next 3Y74.06%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE TRUST / DHC FAQ

Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE TRUST?

ChartMill assigns a fundamental rating of 2 / 10 to DHC.


Can you provide the valuation status for DIVERSIFIED HEALTHCARE TRUST?

ChartMill assigns a valuation rating of 0 / 10 to DIVERSIFIED HEALTHCARE TRUST (DHC). This can be considered as Overvalued.


How profitable is DIVERSIFIED HEALTHCARE TRUST (DHC) stock?

DIVERSIFIED HEALTHCARE TRUST (DHC) has a profitability rating of 1 / 10.


Can you provide the financial health for DHC stock?

The financial health rating of DIVERSIFIED HEALTHCARE TRUST (DHC) is 4 / 10.


Can you provide the expected EPS growth for DHC stock?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE TRUST (DHC) is expected to grow by 36.87% in the next year.